All Stocks
pharma

AMGN — Amgen Inc.

Conviction80
Congress 90d2
Insider 90d0
Markets0
Lobbying10
Contracts1
CountryUS

AMGN

Amgen Inc.

pharma
80STRONG1 source agree
📋 Lobbying

Congressional trades

Last 90 days
2 buy0 sell1 legislator
  • buy Maria Elvira Salazar(Republican) · Apr 17, 2026
  • buy Maria Elvira Salazar(Republican) · Mar 24, 2026

Prediction markets

No prediction markets reference this stock.

Lobbying filings

Last 2 years
  • ALPINE GROUP PARTNERS, LLC.$50K · 2026 first_quarter
    MMMTAXTRD
  • OGR$50K · 2026 first_quarter
    MMMTAX
  • CAPITOL COUNSEL LLC$50K · 2026 first_quarter
    MMM
  • SIGHTLINE ADVOCACY, LLC$20K · 2026 first_quarter
    HCR
  • EMPIRE CONSULTING GROUP$50K · 2026 first_quarter
    HCR
  • TIBER CREEK GROUP$60K · 2026 first_quarter
    HCRMMM
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.$8K · 2026 first_quarter
    HCR
  • FORBES-TATE$80K · 2026 first_quarter
    BUDMEDMMMTAX
  • S-3 GROUP$60K · 2026 first_quarter
    BUDHCR
  • MARSHALL & POPP, LLC$60K · 2026 first_quarter
    CPTPHATRD

Country exposure

Primary domicile
🇺🇸 United States48/100
Posture: opportunityView United States

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

$773.9M · 0% defense
  • Department of Health and Human Services$773.9M · Sep 30, 2022
dcb3fcf